Best Radiotherapy pediatric oncologists: TOP 146 doctors

Dr. Marat Khaikin is a Senior surgeon, Chaim Sheba Medical Center, a specialist in colorectal surgery, proctology and laparoscopic gastrointestinal tract in Assuta Hospital, Israel.

Head of the Onco-Gynecology Department and Lung Cancer Treatment Subdivision, Chief Physician, specializes in Radiotherapy and Brachytherapy in Gynecology.

Oncologist, Radiologist

Radiotherapist

Children's Oncologist

Head of the Department of Pediatric Hematology and Oncology.

Dr. Gal Goldstein is a leading specialist in Pediatric Oncology and Hemato-Oncology at Hadassah Medical Center. He is the Head of the Pediatric Oncology and Hemato-Oncology Department at Hadassah Hospital Ein Kerem.

Dr. Goldstein has over 20 years of experience. He focuses on retinoblastoma, precision medicine, and haploidentical . He graduated from Tel Aviv University. In 2019-2020, Forbes named him one of the best doctors in Israel.

Dr. Goldstein is a member of The Israel Society of Pediatric Hematology and Oncology, The Israeli Cancer Association, and The International Society of Pediatric Oncology. He is dedicated to advancing pediatric cancer care.

Dr. Alon Pikarsky is a board-certified general and colorectal surgeon at Hadassah Medical Center. He received his Israel Board Certification in General Surgery in 1998. He has led the Medical Students Program in Surgery since 1997. Since 2000, he has also served as Residency Program Director.

Dr. Pikarsky is known for his academic leadership. He has worked as an instructor in surgery since 1995, a lecturer since 1999, and a senior lecturer since 2005. He is an active member of several surgical associations. Dr. Pikarsky speaks both English and Hebrew fluently.

Oncologist

Oncologist

Oncologist

Oncologist

• Uses intensity-modulated radiation therapy (IMRT) for precise targeting in radiotherapy.
• Received international training in India, which broadened his global perspective on radiotherapy practices.
• Holds a DM in Clinical Hematology from Medical College, Calcutta.
• Member of professional oncology organizations, staying informed about the latest developments in radiotherapy.
• Recognized with awards for dedication and excellence in the medical field.

Field of Speciality: Urology
Date of Birth: 1980
School of Medicine:  Istanbul University School of Medicine
Graduate Medical Education: University of Health Sciences Taksim Training & Research Hospital
Fellowship: Urological Oncology and Laparoscopic Urology Department of Urology SLK Kliniken Heilbronn University of Heidelberg, Germany
Foreign Language: English

Having graduated from Istanbul University, Faculty of Medicine in Istanbul, he pursued Urological Surgery residency at University of Health Sciences Taksim Training & Research Hospital, Istanbul from 2005 to 2010. He subsequently completed fellowship training in Urological Oncology and Laparoscopic Urology at Department of Urology, Heilbronn, Heidelberg University, Germany.Dr. Taş is able to provide patients curative surgery that is extremely precise, preserves sexual function, has minimal blood loss, minimal pain and quick recovery.

Firsts of Safe Urology Clinic in Turkey: Penis injections of:
Cellular derived from adipose tissue
mesenchymal Cellular
Male-Shot

​

After graduating from Istanbul Medical Faculty in 2004, Dr. Tuncay Taş completed his specialization in Urology at Taksim Training and Research Hospital in 2010. After the training he received in 2006 and 2007 at the “Laparoscopy, Robotics and Oncology Center” of Heildelberg University, Heilbronn SLK Hospital, Germany, he continues to serve his patients in Turkey, especially in the field of Laparoscopic/Robotic Surgery. The majority of Tuncay Taş’s urology practice consists of man sexual health, cancer diagnosis and treatments

His sexual health and wellness practice offers cutting-edge technologies and treatment options for men. Dr Tas offers unique training and clinical protocols for practitioners who want to implement   Penile Implants , Penile Enhancement , SafeFill and MaleShot  into their practice. Dr Taş and his team presented the results of combined P.R.P (MALE-P-SHOT) and SVF application to the penis for the first time in Turkey at the scientific congress and shared the clinical results of these applications. It is also one of the first 5 centers in the world to publish the results of P.R.P (P.SHOT) applications. Dr Taş is one of the urology instructors at ISSCA who is fully involved in regenerative medicine.

(Source: At the congress organized by İHA International Cellular Therapies Association, Dr. Tuncay Taş shared his cell research in clinical regenerative medicine and erectile dysfunction. 2019, Sexual Medicine-Original Research2021, Apr;9(2):100313.doi:10.1016/j.esxm.2020.100313. Epub 2021 30 January.)

​

Recently Dr. Tas has developed a safe and effective treatment to improve penile circumference and has conducted training with a UK-based certification programme. This novel technique has been shown to have impressive and durable cosmetic results.

​

​

OTHER AREAS OF FOCUS

Robotic prostatectomy, Radical prostatectomy, HoLEP, Donor nephrectomy, Nephrectomy, Robotic surgery, Laparoscopic surgery, Prostate cancer, Kidney cancer, Bladder cancer, Testicular cancer, Retroperitoneal lymph node dissection for testicular cancer, Erectile dysfunction, Sexual dysfunction, Male in, Varicocelectomy, Male hypogonadism, Penile implant insertion, Urethroplasty, Penile reconstruction, Penile enlargement, Urethral reconstruction, Artificial urinary sphincter implantation, Bladder injection, Urodynamic testing, Bladder augmentation, Urinary diversion, Urethral stricture, Ureteral obstruction, HIPEC, Reconstructive surgery, Laparoscopic surgery, preservation, Minimally invasive surgery, Hypospadias

​

Membership of Scientific Organizations

Turkish Association of Urology
Turkish Medical Association
Association of Endourology
European Association of Urology
International Society for Applications

• Publications
https://scholar.google.com/citations?user=CA59D8UAAAAJ&hl=en

​

Dr. Raj Nagarkar is a leading Surgical Oncologist with 19 years of experience. He has performed over 50,000 cancer surgeries. His main focus areas are Breast and Thoracic Surgical Oncology. He is involved in more than 200 clinical trials and has contributed to many national and international publications.

Dr. Nagarkar trained in Surgical Oncology at Tata Memorial Hospital, Mumbai. He also holds an MRCS from the Royal College of Surgeons, Edinburgh. He teaches DNB Superspecialty Surgical Oncology and Breast Surgery at Maharashtra University of Health Sciences. Dr. Nagarkar is dedicated to improving the quality of life for his patients.

Chief Physician of Helios Redeyt Oncology Department

Areas of Interest

• Breast Cancer
• Prostate Cancer
• Gastrointestinal Sy Tumors
• Gynecological Tumors
• Brain Tumors
• Lung Cancer

Education
2021:

• Professor Title, Health Sciences University Hamidiye Faculty of Medicine

2017 – 2018:

• Master's Degree in Phytotherapy, Department of Pharmacognosy, Faculty of Pharmacy, Istanbul University

2015:

• Associate Professor Title

1996:

• Radiation Oncology Specialization, Princess Margaret Hospital, Toronto, Canada

1994 – 1998:

• Radiation Oncology Specialization, Şişli Etfal Training and Research Hospital

1982 – 1988:

• Trakya University Faculty of Medicine

Work Experience
2024:

• Neolife Medical Center – Biruni University

2021 – 2024:

• Health Sciences University (Hamidiye Faculty of Medicine – Bursa Medical Faculty – Izmir Medical Faculty – Lecturer)

2020 – 2024:

• SBÜ Başakşehir Çam and Sakura City Hospital – Education and Administrative Officer

2015 – 2020:

• Dr. Sadi Konuk Training and Research Hospital – Radiation Oncology Clinical Department Setup and Administrative Officer

2013 – 2020:

• Gelişim University – Lecturer, Radiation Therapy Technician Program

2009 – 2015:

• Istanbul Training and Research Hospital, Radiation Oncology Center Setup, Clinical Administrative Responsibility, and Chief Assistant

1998 – 2009:

• Şişli Etfal Training and Research Hospital, Radiation Oncology Clinic Chief Assistant

Professional Trainings
2023:

• Project Creation and Development on Artificial Intelligence and Radiotherapy Treatment Planning Sys with Yıldız Technical University

2023:

• Hydrogel Space Oar Application and Certification Training, Başakşehir Çam and Sakura City Hospital

2015:

• Turkish Radiation Oncology Association (Mammography Working Group, Integrative Working Group, Stereotactic Working Group, Uro-Oncology Working Group), Researcher

2020:

• Hydrogel Space Oar Application and Certification Training, Başakşehir Çam and Sakura City Hospital

2018:

• Distance Good Clinical Practices Training; Basic Good Clinical Practices Course

2011:

• Lifelong Learning Program Leonardo da Vinci Mobility Projects, European Union Education and Youth Programs Directorate

2008:

• Brachytherapy Training, Istanbul University, Oncology Institute

Memberships
2022 – 2024:

• President of Sakura Science and Academician Association (SABADER)

2023:

• Turkish Radiation Oncology Association, Integrative Working Group Executive Board Member

2021:

• Cam & Sakura Medical Journal, Section Editor

2018:

• Interdisciplinary Oncology Association, Substitute Member of the Executive Board

1995:

• Turkish Radiation Oncology Association

1989:

• Turkish Medical Association

Scientific Works

• A.1 Karacetin D, Yalcin B, Okten B, Oztürk S, Maral O, Incekara O (2009). Capecitabine and oxaliplatin (XELOX) as first-line treatment for patients with metastatic colorectal cancer. JBUON, 605-608
• A.2 Yılmaz O B, Karacetin D, Kabukcuoglu F, Taskin T, Yener S (2011). Immunohistochemical study of E-cadherin and β-catenin expression in colorectal carcinomas. Pol J Pathol, 62(1), 19-24
• A.3 Karacetin D, Cakir A, Agaoglu F, Çamlıca H, Ergen A, Dizdar Y, Darendeliler E (2010). Dose distribution in 3-dimensional conformal radiotherapy for prostate cancer: comparison of femur doses for four treatment techniques. Journal of Radiotherapy in Practice, 41-51
• A.4 Baycan D, Karacetin D, Balkanay A, Barut Y (2012). Field-in-field IMRT versus 3D-CRT of the breast. Cardiac vessels, ipsilateral lung, and contralateral breast absorbed doses in patients with left-sided lumpectomy: a dosimetric comparison. Jpn J Radiol, DOI: 10.1007/s